Heart Failure With Preserved Ejection Fraction: Prevention and Management

被引：14
作者：
Cilia, Lindsey [1 ,2 ]
Saeed, Anum [1 ,2 ]
Ganga, Harsha V. [1 ,2 ,3 ]
Wu, Wen-Chih [1 ,2 ,3 ]
机构：
[1] Vet Affairs Med Ctr, Div Cardiol, Providence, RI USA
[2] Brown Univ, Dept Cardiol, Alpert Med Sch, Providence, RI 02912 USA
[3] Miriam Hosp, Ctr Cardiac Fitness, Providence, RI 02906 USA
来源：
AMERICAN JOURNAL OF LIFESTYLE MEDICINE | 2019年 / 13卷 / 02期
关键词：
dyspnea; mortality; outcomes; patient admission; prevention; randomized trials; LEFT-VENTRICULAR HYPERTROPHY; TYPE-2; DIABETES-MELLITUS; BODY-MASS INDEX; DIASTOLIC DYSFUNCTION; BLOOD-PRESSURE; CARDIOVASCULAR OUTCOMES; OLDER PATIENTS; ARTERIAL STIFFNESS; CHOLESTEROL LEVELS; EXERCISE CAPACITY;
D O I：
10.1177/1559827617695219
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Heart failure with preserved ejection fraction (HFpEF) is a complex clinical syndrome that constitutes nearly half of all heart failure cases. Because of lack of effective pharmacological targets to improve outcomes, the emphasis of the management and prevention of HFpEF should be through control of risk factors. This review will use the framework proposed by the American Heart Association on 7 simple measures ("Life's Simple 7") that involves diet and lifestyle changes to achieve ideal cardiovascular health. These 7 measures include (1) smoking, (2) obesity, (3) exercise, (4) diet, (5) blood pressure, (6) cholesterol, and (7) glucose control, which can help control the most common comorbidities and risk factors associated with HFpEF, such as hypertension, diabetes, and obesity. Therefore, application of these 7 simple measures would be a patient-centered and cost-effective way of prevention and management of HFpEF.
引用
收藏
页码：182 / 189
页数：8
相关论文
共 99 条
[21]   LXRα improves myocardial glucose tolerance and reduces cardiac hypertrophy in a mouse model of obesity-induced type 2 diabetes [J].
Cannon, Megan V. ;
Sillje, Herman H. W. ;
Sijbesma, Jurgen W. A. ;
Khan, Mohsin A. F. ;
Steffensen, Knut R. ;
van Gilst, Wiek H. ;
de Boer, Rudolf A. .
DIABETOLOGIA, 2016, 59 (03) :634-643
[22]   Concomitant Diabetes Mellitus and Heart Failure [J].
Cas, Alessandra Dei ;
Fonarow, Gregg C. ;
Gheorghiade, Mihai ;
Butler, Javed .
CURRENT PROBLEMS IN CARDIOLOGY, 2015, 40 (01) :7-43
[23]   Magnesium supplementation, metabolic and inflammatory markers, and global genomic and proteomic profiling: a randomized, double-blind, controlled, crossover trial in overweight individuals [J].
Chacko, Sara A. ;
Sul, James ;
Song, Yiqing ;
Li, Xinmin ;
LeBlanc, James ;
You, Yuko ;
Butch, Anthony ;
Liu, Simin .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2011, 93 (02) :463-473
[24]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[25]   The perindopril in elderly people with chronic heart failure (PEP-CHF) study [J].
Cleland, John G. F. ;
Tendera, Michal ;
Adamus, Jerzy ;
Freemantle, Nick ;
Polonski, Lech ;
Taylor, Jacqueline .
EUROPEAN HEART JOURNAL, 2006, 27 (19) :2338-2345
[26]   Physical Exercise With Weight Reduction Lowers Blood Pressure and Improves Abnormal Left Ventricular Relaxation in Pharmacologically Treated Hypertensive Patients [J].
Cocco, Giuseppe ;
Pandolfi, Stefano .
JOURNAL OF CLINICAL HYPERTENSION, 2011, 13 (01) :23-29
[27]   The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus [J].
Dawson, A ;
Morris, AD ;
Struthers, AD .
DIABETOLOGIA, 2005, 48 (10) :1971-1979
[28]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[29]   Epidemiology of Heart Failure with Preserved Ejection Fraction [J].
Dhingra A. ;
Garg A. ;
Kaur S. ;
Chopra S. ;
Batra J.S. ;
Pandey A. ;
Chaanine A.H. ;
Agarwal S.K. .
Current Heart Failure Reports, 2014, 11 (4) :354-365
[30]   Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction The Aldo-DHF Randomized Controlled Trial [J].
Edelmann, Frank ;
Wachter, Rolf ;
Schmidt, Albrecht G. ;
Kraigher-Krainer, Elisabeth ;
Colantonio, Caterina ;
Kamke, Wolfram ;
Duvinage, Andre ;
Stahrenberg, Raoul ;
Durstewitz, Kathleen ;
Loeffler, Markus ;
Duengen, Hans-Dirk ;
Tschoepe, Carsten ;
Herrmann-Lingen, Christoph ;
Halle, Martin ;
Hasenfuss, Gerd ;
Gelbrich, Goetz ;
Pieske, Burkert .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (08) :781-791
12345678910